- Home
- IMA vs THCH Comparison
IMA vs THCH Comparison
Compare IMA & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMA | THCH |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | United States | China |
| Employees | 15 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8M | 58.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMA | THCH |
|---|---|---|
| Price | $5.66 | $2.12 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 371.8K | 3.6K |
| Earning Date | 05-15-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.94 | $1.69 |
| 52 Week High | $17.50 | $3.25 |
Technical Indicators
Market Signals| Indicator | IMA | THCH |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 54.45 |
| Support Level | $3.94 | $2.09 |
| Resistance Level | $7.28 | $2.25 |
| Average True Range (ATR) | 0.53 | 0.10 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 63.52 | 78.13 |
Price Performance
Historical ComparisonAbout IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.